| P2093 | author name string | Hong Ding | |
| | Fang Wu | |
| P2860 | cites work | Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. | Q53187654 |
| | Clinical role of FDG PET/CT for methotrexate-related malignant lymphoma. | Q53221352 |
| | Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients. | Q53543032 |
| | Quantum dot bioconjugates for ultrasensitive nonisotopic detection. | Q54135557 |
| | Imaging of Resonant Quenching of Surface Plasmons by Quantum Dots | Q62388095 |
| | In vivo imaging of quantum dots encapsulated in phospholipid micelles | Q78594973 |
| | [Investigation of the in vivo desintegration and transit behavior of tetramethylpyrazine phosphate pulsincap capsule in the gastrointestinal tract of dogs by gamma scintigraphy] | Q79140621 |
| | Characterization of cystic pancreatic masses: relative accuracy of CT and MRI | Q80833659 |
| | Monoclonal antibody pharmacokinetics and pharmacodynamics | Q81951721 |
| | Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu‐labeled bevacizumab in colorectal cancer xenografts | Q82425733 |
| | Noninvasive real-time fluorescence imaging of the lymphatic uptake of BSA-IRDye 680 conjugate administered subcutaneously in mice | Q83289385 |
| | CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis | Q84072960 |
| | Simple high-performance liquid chromatographic method for the determination of tetramethylpyrazine phosphate in very small volumes of dog plasma: application to a pharmacokinetic study | Q94474467 |
| | Quantum dots for live cells, in vivo imaging, and diagnostics | Q24532049 |
| | A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo | Q27668018 |
| | Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target | Q28238573 |
| | Improved green fluorescence | Q28307219 |
| | Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors | Q28395879 |
| | Firefly luciferase gene: structure and expression in mammalian cells | Q29616519 |
| | Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication | Q30389591 |
| | Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates | Q30480648 |
| | Real-time video imaging of protease expression in vivo | Q30499267 |
| | The potential of PET/MR for brain imaging | Q33395378 |
| | Aqueous-phase synthesis of highly luminescent CdTe/ZnTe core/shell quantum dots optimized for targeted bioimaging | Q33412448 |
| | Imaging pancreatic cancer using bioconjugated InP quantum dots | Q33412483 |
| | Nanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons | Q33420721 |
| | Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review | Q33503551 |
| | Tumor targeting and imaging in live animals with functionalized semiconductor quantum rods | Q33531672 |
| | Functionalized near-infrared quantum dots for in vivo tumor vasculature imaging | Q33541408 |
| | PET/NIRF/MRI triple functional iron oxide nanoparticles | Q33727232 |
| | Physiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disorders | Q33797048 |
| | Non-invasive tumor detection in small animals using novel functional Pluronic nanomicelles conjugated with anti-mesothelin antibody. | Q33834277 |
| | Bioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriers. | Q33843190 |
| | Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice | Q33925383 |
| | Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles | Q33994463 |
| | Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging | Q34083326 |
| | 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes | Q34155968 |
| | Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice | Q34328761 |
| | Development and applications of photo-triggered theranostic agents | Q34349286 |
| | Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody | Q34545866 |
| | Scaling down imaging: molecular mapping of cancer in mice | Q34570116 |
| | Automatic generation of absolute myocardial blood flow images using [15O]H2O and a clinical PET/CT scanner | Q34757040 |
| | Molecular imaging of cancer with positron emission tomography | Q34810431 |
| | PET imaging of CXCR4 using copper-64 labeled peptide antagonist | Q34895626 |
| | Integrin targeting for tumor optical imaging | Q34912662 |
| | Molecular imaging in living subjects: seeing fundamental biological processes in a new light | Q35082602 |
| | Tumor localization of an anti-TGF-β antibody and its effects on gliomas | Q39627227 |
| | Biocompatible magnetofluorescent probes: luminescent silicon quantum dots coupled with superparamagnetic iron(III) oxide | Q39663536 |
| | Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle | Q39691681 |
| | Dual functional molecular imaging probe targeting CD20 with PET and optical imaging | Q39840299 |
| | Taxotere chemosensitivity evaluation in mice prostate tumor: validation and diagnostic accuracy of quantitative measurement of tumor characteristics by MRI, PET, and histology of mice tumor | Q39983224 |
| | A microPET/CT system for in vivo small animal imaging | Q40100333 |
| | Optical molecular imaging: from single cell to patient. | Q40106525 |
| | In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft. | Q40107068 |
| | Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier | Q40238876 |
| | Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. | Q41721402 |
| | PET Imaging of Integrin αVβ3 Expression | Q42726009 |
| | Biodistribution Study Using Egg Protein ELISA Kit after Administration of FITC-labeled Ovalbumin Solution and Its Double Liposomes in the In Situ Loop Method, and Its Implication in Oral Immunization | Q42857381 |
| | Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals | Q43253511 |
| | Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers | Q43262208 |
| | F-18 FDG PET/CT findings in a patient with bilateral orbital and gastric mucosa-associated lymphoid tissue lymphomas | Q43289403 |
| | In situ blood-brain barrier transport of nanoparticles | Q44684307 |
| | Combined microPET/CT for imaging of hepatocellular carcinoma in mice | Q46094410 |
| | Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment | Q46218695 |
| | Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy | Q46687238 |
| | Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy | Q46708263 |
| | Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner | Q47245137 |
| | Fluorescence imaging of the lymph node uptake of proteins in mice after subcutaneous injection: molecular weight dependence. | Q47324299 |
| | Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI. | Q47781728 |
| | Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier | Q48600278 |
| | DNA double strand break repair in brain: reduced NHEJ activity in aging rat neurons | Q48728157 |
| | MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration | Q48876682 |
| | Improved quantitation for PET/CT image reconstruction with system modeling and anatomical priors. | Q51096232 |
| | Gold nanorod--siRNA induces efficient in vivo gene silencing in the rat hippocampus | Q35093276 |
| | Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging | Q35558668 |
| | PET/CT today and tomorrow | Q35635195 |
| | PET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides | Q35641937 |
| | Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets | Q35650596 |
| | In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene | Q35854802 |
| | Pharmacokinetics, lymph node uptake, and mechanistic PK model of near-infrared dye-labeled bevacizumab after IV and SC administration in mice | Q35888386 |
| | OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice | Q35897012 |
| | Using imaging biomarkers to accelerate drug development and clinical trials | Q36039936 |
| | PET/CT Imaging and Radioimmunotherapy of Prostate Cancer | Q36085426 |
| | Towards detecting the HER-2 receptor and metabolic changes induced by HER-2-targeted therapies using medical imaging. | Q36324211 |
| | NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. | Q36613467 |
| | Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications | Q36919600 |
| | Quantum dots - nano-sized probes for the exploration of cellular and intracellular targeting | Q36942277 |
| | In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice. | Q37129823 |
| | Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives | Q37130501 |
| | In vivo far-red luminescence imaging of a biomarker based on BRET from Cypridina bioluminescence to an organic dye. | Q37337813 |
| | Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses | Q37436554 |
| | Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer | Q37457888 |
| | Potential of labeling monoclonal antibodies for positron emission tomography and magnetic resonance imaging. | Q37577605 |
| | Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis | Q37695932 |
| | Immuno-positron emission tomography in cancer models | Q37720853 |
| | Small-animal positron emission tomography as a tool for neuropharmacology | Q37769735 |
| | Molecular tracers for the PET and SPECT imaging of disease | Q37785499 |
| | Assessing antibody pharmacokinetics in mice with in vivo imaging | Q37840897 |
| | Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer | Q37864158 |
| | Molecular imaging with nucleic acid aptamers | Q37916658 |
| | Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model | Q39412224 |
| | Evaluation of (111)In labeled antibodies for SPECT imaging of mesothelin expressing tumors | Q39489887 |
| | Bioconjugation of luminescent silicon quantum dots for selective uptake by cancer cells | Q39562424 |
| | Multimodal imaging probes based on Gd-DOTA conjugated quantum dot nanomicelles | Q39581694 |
| | 5,7-Dimethoxyflavone and multiple flavonoids in combination alter the ABCG2-mediated tissue distribution of mitoxantrone in mice | Q39600534 |
| | Reporter gene imaging in therapy and diagnosis | Q39616114 |
| | In vivo targeted cancer imaging, sentinel lymph node mapping and multi-channel imaging with biocompatible silicon nanocrystals. | Q39622987 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 11 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| | medical imaging | Q931309 |
| | physiological phenomenon | Q66615932 |
| P304 | page(s) | 1040-1053 | |
| P577 | publication date | 2012-11-05 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | Image guided biodistribution and pharmacokinetic studies of theranostics | |
| P478 | volume | 2 | |